Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122947182 | 12294718 | 2 | F | 2010 | 20160628 | 20160422 | 20160706 | EXP | PHHY2012FR068925 | NOVARTIS | 59.00 | YR | F | Y | 0.00000 | 20160706 | MD | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122947182 | 12294718 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | UNK | 22334 | ||||||||||
122947182 | 12294718 | 2 | SS | AFINITOR | EVEROLIMUS | 1 | Unknown | 10 MG, QD | 22334 | 10 | MG | QD | |||||||
122947182 | 12294718 | 3 | SS | AFINITOR | EVEROLIMUS | 1 | Unknown | 5 MG, QD | 22334 | 5 | MG | QD | |||||||
122947182 | 12294718 | 4 | SS | AFINITOR | EVEROLIMUS | 1 | 7.5 MG, QD | 22334 | 7.5 | MG | QD | ||||||||
122947182 | 12294718 | 5 | C | EXEMESTANE. | EXEMESTANE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122947182 | 12294718 | 1 | Renal cancer metastatic |
122947182 | 12294718 | 2 | Renal cell carcinoma |
122947182 | 12294718 | 3 | Breast cancer |
122947182 | 12294718 | 5 | Breast cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122947182 | 12294718 | OT |
122947182 | 12294718 | HO |
122947182 | 12294718 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122947182 | 12294718 | Acute generalised exanthematous pustulosis | |
122947182 | 12294718 | Aphthous ulcer | |
122947182 | 12294718 | Blister | |
122947182 | 12294718 | Dermatitis acneiform | |
122947182 | 12294718 | Dry skin | |
122947182 | 12294718 | Eczema | |
122947182 | 12294718 | Epstein-Barr virus infection | |
122947182 | 12294718 | Feeding disorder | |
122947182 | 12294718 | Malignant neoplasm progression | |
122947182 | 12294718 | Nausea | |
122947182 | 12294718 | Neutropenia | |
122947182 | 12294718 | Oral pain | |
122947182 | 12294718 | Pruritus | |
122947182 | 12294718 | Rash pustular | |
122947182 | 12294718 | Skin plaque | |
122947182 | 12294718 | Stomatitis | |
122947182 | 12294718 | Toxic skin eruption | |
122947182 | 12294718 | Weight decreased | |
122947182 | 12294718 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122947182 | 12294718 | 1 | 2010 | 0 | ||
122947182 | 12294718 | 2 | 20150214 | 20150304 | 0 | |
122947182 | 12294718 | 3 | 20150318 | 20150513 | 0 | |
122947182 | 12294718 | 4 | 20150514 | 20151118 | 0 |